Antimicrobial Hospital Textile Market - Global Industry Analysis

Market Overview

The Global Antimicrobial Hospital Textile Market accounted for USD 9.45 Billion in 2020 and is expected to reach USD 14.79 Billion by 2028, growing at a CAGR of 6.6% from 2020 to 2028.

Antimicrobial textiles are fibre substrates that have been treated with antimicrobial agents. They extend the life of consumer goods and increase their efficiency. The industry is expected to expand as demand for antimicrobial sportswear grows, as does public concern about health and hygiene. Antimicrobial textiles demand development is hampered by raw material price fluctuations and strict environmental regulations in industrialised regions. Over the projected era, however, the growth of the healthcare sector in emerging regions is expected to augment the growth for major companies.

Within technical textiles, hospital textile is a significant product group. Technical textiles are non-commodity textiles that are mostly found in non-apparel applications such as industrial textiles, hospital textiles, sport textiles, and geotextiles.

COVID-19 Impact Analysis

COVID-19 has caused havoc in a variety of sectors. The demand for different goods has greatly decreased as a result of the disruption. Owing to federal restrictions or a lack of demand, manufacturing plants are forced to close. In this pandemic scenario, demand for antimicrobial hospital items such as mattresses, gloves, socks, surgical supplies & wipes, sheets & blankets has risen dramatically. Despite this, suppliers are having trouble obtaining raw materials for the manufacturing of various antimicrobial hospital items. The increase in antimicrobial hospital supplies is insufficient to cover the output volume deficit caused by the COVID-19 pandemic.

To deter the dissemination of COVID-19 across the world, export operations have been significantly decreased or entirely halted. As a result, trade by air, sea, and land was halted for almost three months around the world. Both of these trends have reduced demand for a variety of goods across markets, but demand for antimicrobial hospital textiles has skyrocketed.

Growth Factors

One of the major growth drivers for the Global Antimicrobial Hospital Textile Market is the Growing consumer awareness about hygiene in emerging market. Due to increasing awareness of the possible risks of microorganisms on textiles as well as on the buyer of textiles, owing to increasing literacy rates and public awareness campaigns. The demand for antimicrobial hospital textiles is increasing as people become more conscious of hygiene, their disposable income rises, their lifestyles change, their health concerns intensify, and pollution levels rise. Antimicrobial hospital textiles are becoming more popular as the healthcare sector expands.

Another factor of growth in this market is Rising demand for antimicrobial sportswear and apparel. Due to the increasing awareness of fitness and wellness, global demand for sportswear and apparel continues to increase. This increase can be due to a variety of causes, including increased health literacy, increasing disposable incomes, and advances in wireless technology. Demand will rise as a result of the promotion of a healthy and more physically active lifestyle. Both of these factors would contribute to the antimicrobial textiles market's growth over the projected period.

Report Scope :

Application Segment Analysis Preview

Upholstery segment dominates the market of the antimicrobial medical textiles, due to its widespread use in hospitals and clinics It includes Bottom sheets, pillowcases, shower & modesty curtains, thermal blankets. Since these materials are used often, they are subject to a lot of wear and tear. This will boost interest in this market even further. Suits, tops, hats, caps, masks, patient gowns, precaution gowns, jackets, and other items are included in the medical uniform & apparels section. A big growth driver in this segment will be the jobs in the medical sector and an increase in the number of patients.

Finishing Agent Segment Analysis Preview

Metallic salts-based products has the largest share in the market accounting for more than 55% of global sales in 2020. Due to their superior properties, which led to increased use in food manufacturing. Manufacturers favour silver metallic salts because of their ease of use and ability to have an excellent antimicrobial finish. Since triclosan has been classified as a hazardous chemical, demand is projected to decline over the forecast period. The antimicrobial properties of the quaternary ammonium compound help to expand its application reach by performing a variety of actions such as bacterial cell destruction, protein denaturation, and cell multiplication inhibition,

Regional Segment Analysis Preview

The Global Antimicrobial Hospital Textile Market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East Africa.

In terms of sales, Asia-Pacific is projected to be the fastest growing country. During the forecast period, it is projected to rise at a CAGR of 9.20%. This is due to an increase in demand for hospital textiles in the country as the healthcare industry expands. The market for high-quality cloth in the area is projected to boost the demand for antimicrobial hospital textiles, with textile being amongst the main industries in countries like China and India. China, India, and Indonesia, among other APAC emerging economies, will play a significant role in the development of the antimicrobial hospital textiles industry.

In North America and Europe, improved medical infrastructure is likely to result in increased demand for antimicrobial medical textiles. Countries like Germany, the United States, and the United Kingdom fuel demand in these areas. The growing use of implantable products in North America is projected to drive the medical textiles industry, owing to deficiencies in conventional opioid therapies and a variety of other chronic disorders. Furthermore, ongoing biotechnology advances will result in the commercialization of new and improved drugs, boosting consumer development in the field.

Key Market Players and Competitive Landscape

Some of the prominent players operating in the Global Antimicrobial Hospital Textile Market are Baltex, Meditex Technology, Surgicotfab Textiles Private Limited, Medtronic, Toyobo Co. Ltd., Smartfiber AG, Swicofil AG, Herculite Inc., Smith & Nephew Plc., Sinterama and Others.

The main players in this industry are working to extend their global business presence. Companies have been raising their investments in emerging countries in order to take advantage of lower trade barriers. Silver processing is widely used in antimicrobial medical textiles. To increase retail sales, suppliers are entering into distribution arrangements with healthcare chains.

The Global Antimicrobial Hospital Textile Market is segmented as follows:-

Application

• Medical Uniform & Apparels
• Upholstery
• Surgical Textiles
• Incontinence Care Garments
• Wound Treatment
• Others

FDA Class

• Class I
• Class II
• Class III

Finishing Agent

• Quaternary Ammonium
• Metallic Salts
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter No. 1: Introduction
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• Chapter No. 2: Executive Summary
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Application
      • 2.1.1.2. Market Attractiveness Analysis, By FDA Class
      • 2.1.1.3. Market Attractiveness Analysis, By Finishing Agent
      • 2.1.1.4. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Antimicrobial Hospital Textile Market, 2016 – 2028 (USD Million)
  • 2.4. Insights from Primary Respondents
• Chapter No. 3: COVID 19 Impact Analysis
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• Chapter No. 4: Antimicrobial Hospital Textile Market – Application Segment Analysis
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Application, 2020 & 2028
  • 4.2. Medical Uniform & Apparels
    • 4.2.1. Market Size and Forecast, By Region (USD Million)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Uphulstery
    • 4.3.1. Market Size and Forecast, By Region (USD Million)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Surgical Textiles
    • 4.4.1. Market Size and Forecast, By Region (USD Million)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Incontinence Care Garments
    • 4.5.1. Market Size and Forecast, By Region (USD Million)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.6. Wound Treatment
    • 4.6.1. Market Size and Forecast, By Region (USD Million)
    • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.7. Others
    • 4.7.1. Market Size and Forecast, By Region (USD Million)
    • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 5: Antimicrobial Hospital Textile Market – FDA Class Segment Analysis
  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By FDA Class, 2020 & 2028
  • 5.2. Class I
    • 5.2.1. Market Size and Forecast, By Region (USD Million)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Class II
    • 5.3.1. Market Size and Forecast, By Region (USD Million)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.4. Class III
    • 5.4.1. Market Size and Forecast, By Region (USD Million)
    • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 6: Antimicrobial Hospital Textile Market – Finishing Agent Segment Analysis
  • 6.1. Overview
    • 6.1.1. Market Revenue Share, By Finishing Agent, 2020 & 2028
  • 6.2. Quaternary Ammonium
    • 6.2.1. Market Size and Forecast, By Region (USD Million)
    • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.3. Metallic Salts
    • 6.3.1. Market Size and Forecast, By Region (USD Million)
    • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.4. Others
    • 6.4.1. Market Size and Forecast, By Region (USD Million)
    • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 7: Antimicrobial Hospital Textile Market – Regional Analysis
  • 7.1. Overview
    • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.2.2. North America Market Revenue, By Application, 2016 – 2028
    • 7.2.3. North America Market Revenue, By FDA Class, 2016 – 2028
    • 7.2.4. North America Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.2.5. U.S.
      • 7.2.5.1. U.S. Market Revenue, By Application, 2016 – 2028
      • 7.2.5.2. U.S. Market Revenue, By FDA Class, 2016 – 2028
      • 7.2.5.3. U.S. Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.2.6. Canada
      • 7.2.6.1. Canada Market Revenue, By Application, 2016 – 2028
      • 7.2.6.2. Canada Market Revenue, By FDA Class, 2016 – 2028
      • 7.2.6.3. Canada Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.2.7. Mexico
      • 7.2.7.1. Mexico Market Revenue, By Application, 2016 – 2028
      • 7.2.7.2. Mexico Market Revenue, By FDA Class, 2016 – 2028
      • 7.2.7.3. Mexico Market Revenue, By Finishing Agent, 2016 – 2028
  • 7.3. Europe
    • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.3.2. Europe Market Revenue, By Application, 2016 – 2028
    • 7.3.3. Europe Market Revenue, By FDA Class, 2016 – 2028
    • 7.3.4. Europe Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.3.5. Germany
      • 7.3.5.1. Germany Market Revenue, By Application, 2016 – 2028
      • 7.3.5.2. Germany Market Revenue, By FDA Class, 2016 – 2028
      • 7.3.5.3. Germany Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.3.6. France
      • 7.3.6.1. France Market Revenue, By Application, 2016 – 2028
      • 7.3.6.2. France Market Revenue, By FDA Class, 2016 – 2028
      • 7.3.6.3. France Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.3.7. U.K.
      • 7.3.7.1. U.K. Market Revenue, By Application, 2016 – 2028
      • 7.3.7.2. U.K. Market Revenue, By FDA Class, 2016 – 2028
      • 7.3.7.3. U.K. Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.3.8. Italy
      • 7.3.8.1. Italy Market Revenue, By Application, 2016 – 2028
      • 7.3.8.2. Italy Market Revenue, By FDA Class, 2016 – 2028
      • 7.3.8.3. Italy Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.3.9. Spain
      • 7.3.9.1. Spain Market Revenue, By Application, 2016 – 2028
      • 7.3.9.2. Spain Market Revenue, By FDA Class, 2016 – 2028
      • 7.3.9.3. Spain Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.3.10. Rest of Europe
      • 7.3.10.1. Rest of Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.10.2. Rest of Europe Market Revenue, By FDA Class, 2016 – 2028
      • 7.3.10.3. Rest of Europe Market Revenue, By Finishing Agent, 2016 – 2028
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.4.2. Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 7.4.3. Asia Pacific Market Revenue, By FDA Class, 2016 – 2028
    • 7.4.4. Asia Pacific Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.4.5. China
      • 7.4.5.1. China Market Revenue, By Application, 2016 – 2028
      • 7.4.5.2. China Market Revenue, By FDA Class, 2016 – 2028
      • 7.4.5.3. China Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.4.6. Japan
      • 7.4.6.1. Japan Market Revenue, By Application, 2016 – 2028
      • 7.4.6.2. Japan Market Revenue, By FDA Class, 2016 – 2028
      • 7.4.6.3. Japan Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.4.7. India
      • 7.4.7.1. India Market Revenue, By Application, 2016 – 2028
      • 7.4.7.2. India Market Revenue, By FDA Class, 2016 – 2028
      • 7.4.7.3. India Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.4.8. South Korea
      • 7.4.8.1. South Korea Market Revenue, By Application, 2016 – 2028
      • 7.4.8.2. South Korea Market Revenue, By FDA Class, 2016 – 2028
      • 7.4.8.3. South Korea Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.4.9. South-East Asia
      • 7.4.9.1. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 7.4.9.2. South-East Asia Market Revenue, By FDA Class, 2016 – 2028
      • 7.4.9.3. South-East Asia Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.4.10. Rest of Asia Pacific
      • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.10.2. Rest of Asia Pacific Market Revenue, By FDA Class, 2016 – 2028
      • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Finishing Agent, 2016 – 2028
  • 7.5. Latin America
    • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.5.2. Latin America Market Revenue, By Application, 2016 – 2028
    • 7.5.3. Latin America Market Revenue, By FDA Class, 2016 – 2028
    • 7.5.4. Latin America Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.5.5. Brazil
      • 7.5.5.1. Brazil Market Revenue, By Application, 2016 – 2028
      • 7.5.5.2. Brazil Market Revenue, By FDA Class, 2016 – 2028
      • 7.5.5.3. Brazil Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.5.6. Argentina
      • 7.5.6.1. Argentina Market Revenue, By Application, 2016 – 2028
      • 7.5.6.2. Argentina Market Revenue, By FDA Class, 2016 – 2028
      • 7.5.6.3. Argentina Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.5.7. Rest of Latin America
      • 7.5.7.1. Rest of Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.7.2. Rest of Latin America Market Revenue, By FDA Class, 2016 – 2028
      • 7.5.7.3. Rest of Latin America Market Revenue, By Finishing Agent, 2016 – 2028
  • 7.6. The Middle-East and Africa
    • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 7.6.2. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
    • 7.6.3. The Middle-East and Africa Market Revenue, By FDA Class, 2016 – 2028
    • 7.6.4. The Middle-East and Africa Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.6.5. GCC Countries
      • 7.6.5.1. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 7.6.5.2. GCC Countries Market Revenue, By FDA Class, 2016 – 2028
      • 7.6.5.3. GCC Countries Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.6.6. South Africa
      • 7.6.6.1. South Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.6.2. South Africa Market Revenue, By FDA Class, 2016 – 2028
      • 7.6.6.3. South Africa Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.6.7. Rest of Middle-East Africa
      • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By FDA Class, 2016 – 2028
      • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Finishing Agent, 2016 – 2028
• Chapter No. 8: Antimicrobial Hospital Textile Market – Industry Analysis
  • 8.1. Introduction
  • 8.2. Market Drivers
    • 8.2.1. Driving Factor 1 Analysis
    • 8.2.2. Driving Factor 2 Analysis
  • 8.3. Market Restraints
    • 8.3.1. Restraining Factor Analysis
  • 8.4. Market Opportunities
    • 8.4.1. Market Opportunity Analysis
  • 8.5. Porter’s Five Forces Analysis
  • 8.6. PEST Analysis
  • 8.7. Regulatory Landscape
  • 8.8. Technology Landscape
  • 8.9. Regional Market Trends
    • 8.9.1. North America
    • 8.9.2. Europe
    • 8.9.3. Asia Pacific
    • 8.9.4. Latin America
    • 8.9.5. The Middle-East and Africa
  • 8.10. Pricing Analysis
  • 8.11. Value Chain Analysis
  • 8.12. Downstream Buyers
  • 8.13. Distributors/Traders List
• Chapter No. 9: Competitive Landscape
  • 9.1. Company Market Share Analysis – 2019
    • 9.1.1. Global Antimicrobial Hospital Textile Market: Company Market Share, 2019
    • 9.1.2. Global Antimicrobial Hospital Textile Market, Company Market Revenue, 2016 – 2019 (USD Million)
    • 9.1.3. Global Antimicrobial Hospital Textile Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 9.1.4. Global Antimicrobial Hospital Textile Market: Radar Determinant Chart, 2019
  • 9.2. Strategic Developments
    • 9.2.1. Acquisitions & Mergers
    • 9.2.2. New Product Launch
    • 9.2.3. Regional Expansion
  • 9.3. Company Strategic Developments – Heat Map Analysis
• Chapter No. 10: Company Profiles
  • 10.1. Baltex
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Product Portfolio
    • 10.1.4. Financial Overview
    • 10.1.5. Operating Business Segments
    • 10.1.6. Business Performance
    • 10.1.7. Recent Developments
  • 10.2. Meditex Technology
  • 10.3. Surgicotfab Textiles Private Limited
  • 10.4. Medtronic
  • 10.5. Toyobo Co. Ltd.
  • 10.6. Smartfiber AG
  • 10.7. Swicofil AG
  • 10.8. Herculite Inc.
  • 10.9. Smith & Nephew Plc.
  • 10.10. Sinterama
• Chapter No. 11: Marketing Strategy Analysis
  • 11.1. Marketing Channel
  • 11.2. Direct Marketing
  • 11.3. Indirect Marketing
  • 11.4. Marketing Channel Development Trends
  • 11.5. Economic/Pulitical Environmental Change
• Chapter No. 12: Research Methodology
  • 12.1. Research Methodology
  • 12.2. Phase I - Secondary Research
  • 12.3. Phase II - Data Modeling
    • 12.3.1. Company Share Analysis Model
    • 12.3.2. Revenue Based Modeling
  • 12.4. Phase III - Primary Research
  • 12.5. Research Limitations
    • 12.5.1. Assumptions